突触核蛋白病的体内诊断:皮肤活检与RT-QuIC的比较研究
患者接受皮肤活检免疫荧光和RT-QuIC检测,部分患者因诊断目的行腰椎穿刺检查脑脊液。结果显示免疫荧光在相邻皮肤样本间结果可重复,免疫荧光和RT-QuIC在区分突触核蛋白病与非突触核蛋白病及对照时均显示高敏感性和特异性,但免疫荧光诊断准确性更高。
要点
- 皮肤免疫荧光和RT-QuIC均能高敏感、高特异地区分突触核蛋白病与非突触核蛋白病。
- 免疫荧光在皮肤样本间可重复性好,且诊断准确性优于RT-QuIC。
- 免疫荧光与RT-QuIC在突触核蛋白病中一致性良好,支持用微创皮肤检测替代脑脊液RT-QuIC。
核心结论
- 免疫荧光和RT-QuIC均显示高诊断准确性,免疫荧光价值更优且可重复性最佳,两者在突触核蛋白病中一致性良好。
研究设计与样本
- 患者接受皮肤活检免疫荧光和RT-QuIC检测,部分患者因诊断目的行腰椎穿刺检查脑脊液,检测均对临床诊断设盲。
主要发现
- 免疫荧光在两个相邻皮肤样本对之间显示可重复结果。
- 免疫荧光和RT-QuIC在区分突触核蛋白病与非突触核蛋白病及对照时均显示高敏感性和特异性,但免疫荧光诊断准确性更高。
- 免疫荧光与RT-QuIC在皮肤和脑脊液中均呈现良好一致性。
关键数值与推荐
- 研究提供III级证据表明免疫荧光或RT-QuIC能准确区分突触核蛋白病与非突触核蛋白病。
临床怎么用
- 支持使用创伤更小的皮肤免疫荧光或皮肤RT-QuIC替代脑脊液RT-QuIC作为突触核蛋白病的诊断工具。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine whether (1) immunofluorescence is a reproducible technique in detecting misfolded α-synuclein in skin nerves and subsequently whether (2) immunofluorescence and real-time quaking-induced conversion (RT-QuIC) (both in skin and CSF) show a comparable in vivo diagnostic accuracy in distinguishing synucleinopathies from non-synucleinopathies in a large cohort of patients. METHODS: We prospectively recruited 90 patients fulfilling clinical and instrumental diagnostic criteria for all synucleinopathies variants and non-synucleinopathies (mainly including Alzheimer disease, tauopathies, and vascular parkinsonism or dementia). Twenty-four patients with mainly peripheral neuropathies were used as controls. Patients underwent skin biopsy for immunofluorescence and RT-QuIC; CSF was examined in patients who underwent lumbar puncture for diagnostic purposes. Immunofluorescence and RT-QuIC analysis were made blinded to the clinical diagnosis. RESULTS: Immunofluorescence showed reproducible results between 2 pairs of neighboring skin samples. Both immunofluorescence and RT-QuIC showed high sensitivity and specificity in discriminating synucleinopathies from non-synucleinopathies and controls but immunofluorescence presented higher diagnostic accuracy. Immunofluorescence presented a good level of agreement with RT-QuIC in both skin and CSF in synucleinopathies. CONCLUSIONS: Both immunofluorescence and RT-QuIC showed high diagnostic accuracy, although immunofluorescence displayed the better value as well as optimal reproducibility; they presented a good level of agreement in synucleinopathies, supporting the use of less invasive tests such as skin immunofluorescence or RT-QuIC instead of CSF RT-QuIC as a diagnostic tool for synucleinopathies. CLASSIFICATION OF EVIDENCE: This study provides Class III evidence that immunofluorescence or RT-QuIC accurately distinguish synucleinopathies from non-synucleinopathies.
引用
- Donadio V, Wang Z, Incensi A, et al. In Vivo Diagnosis of Synucleinopathies: A Comparative Study of Skin Biopsy and RT-QuIC. Neurology. 2021. PMID: 33837116. doi:10.1212/WNL.0000000000011935
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。